Supernus Pharmaceuticals
SUPN
SUPN
218 hedge funds and large institutions have $1.2B invested in Supernus Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 80 increasing their positions, 68 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 208 → 218 (+10)
2.04% more ownership
Funds ownership: 94.17% → 96.21% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
218
Holding in Top 10
1
Calls
$2.04M
Puts
$1.2M
Top Buyers
| 1 | +$18.8M | |
| 2 | +$16.4M | |
| 3 | +$11.4M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$10.8M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$9.6M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$12.8M | |
| 3 | -$12.4M | |
| 4 |
First Manhattan
New York
|
-$11.2M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$9.95M |